IP Library Granted Patent US 12,630,574
Granted Patent B2
US 12,630,574 · App. 17/689,162 · Granted May 19, 2026

Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device

Inventors: Bumwoo Park (Yongin-si, KR); Ohyun Kwon (Seoul, KR); Soyeon Kim (Seoul, KR); Virendra Kumar Rai (Hwaseong-si, KR); Juhee Moon (Hwaseong-si, KR); Yongsuk Cho (Hwaseong-si, KR); Byoungki Choi (Hwaseong-si, KR); Jongwon Choi (Yongin-si, KR); Dmitry Kravchuk (Hwaseong-si, KR)
Assignee: SAMSUNG DISPLAY CO., LTD.
C07F15/0033H10K85/342H10K50/11H10K2101/30H10K2101/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,630,574
App. No.
17/689,162
Granted
May 19, 2026
Kind
B2
Abstract

An organometallic compound, represented by Formula 1: wherein, Ln 1 is a ligand represented by Formula 1-1, Ln 2 is a ligand represented by Formula 2-1 or 2-2, n1 is 1, 2, or 3, and n2 is 0, 1, or 2, wherein CY 1 is a benzoquinoline group or a benzoisoquinoline group, X 31 and X 32 are each independently O or S; R 10 , R 21 to R 28 , R 31 to R 37 , R 41 to R 44 , and b10 are as defined herein; and * and *′ each indicate a binding site to M 1 .

Claims (74)

1 . An organometallic compound, represented by Formula 1:

M 1 (Ln 1 ) n1 (Ln 2 ) n2   Formula 1

wherein, in Formula 1,

M 1 is a transition metal,

Ln 1 is a ligand represented by Formula 1-1,

Ln 2 is a ligand represented by Formula 2-1 or 2-2,

n1 is 1, 2, or 3, and

n2 is 0, 1, or 2,

wherein, in Formulae 1-1, 2-1, and 2-2,

CY 1 is a group represented by one of Formulae 3-2 to 3-9:

wherein, in Formulae 3-2 to 3-9,

R 11 to R 18 are each as defined in connection with R 10 , provided that in Formulae 3-2 to 3-6, at least one of R 11 to R 18 is —Si(Q 1 )(Q 2 )(Q 3 ) or —Ge(Q 1 )(Q 2 )(Q 3 ),

X 31 and X 32 are each independently O or S,

R 10 , R 21 to R 28 , R 31 to R 37 , and R 41 to R 44 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 1 -C 60 alkylthio group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkyl aryl group, a substituted or unsubstituted C 7 -C 60 aryl alkyl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted C 2 -C 60 heteroaryl alkyl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —Ge(Q 1 )(Q 2 )(Q 3 ), —N(Q 4 )(Q 5 ), —B(Q 6 )(Q 7 ), —P(Q 8 )(Q 9 ), or —P(═O)(Q 8 )(Q 9 ),

two or more of R 10 (s) are optionally bonded together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group,

two or more of R 21 to R 28 are optionally bonded together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group,

two or more of R 31 to R 37 are optionally bonded together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group,

two or more of R 41 to R 44 are optionally bonded together to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group,

neighboring two or more of R 10 , R 21 to R 28 , R 31 to R 37 , and R 41 to R 44 are optionally linked to form a substituted or unsubstituted C 5 -C 30 carbocyclic group or a substituted or unsubstituted C 1 -C 30 heterocyclic group,

b10 is 1, 2, 3, 4, 5, 6, 7, or 8,

* and *′ each indicate a binding site to M 1 , and

at least one substituent of the substituted C 5 -C 30 carbocyclic group, the substituted C 1 -C 30 heterocyclic group, the substituted C 1 -C 60 alkyl group, the substituted C 2 -C 60 alkenyl group, the substituted C 2 -C 60 alkynyl group, the substituted C 1 -C 60 alkoxy group, the substituted C 1 -C 60 alkylthio group, the substituted C 3 -C 10 cycloalkyl group, the substituted C 1 -C 10 heterocycloalkyl group, the substituted C 3 -C 10 cycloalkenyl group, the substituted C 1 -C 10 heterocycloalkenyl group, the substituted C 6 -C 60 aryl group, the substituted C 7 -C 60 alkyl aryl group, the substituted C 7 -C 60 aryl alkyl group, the substituted C 6 -C 60 aryloxy group, the substituted C 6 -C 60 arylthio group, the substituted C 1 -C 60 heteroaryl group, the substituted C 2 -C 60 alkyl heteroaryl group, the substituted C 2 -C 60 heteroaryl alkyl group, the substituted C 1 -C 60 heteroaryloxy group, the substituted C 1 -C 60 heteroarylthio group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group is:

deuterium, —F, —Cl, —Br, —I, —SF 5 , —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, or a C 1 -C 60 alkylthio group;

a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, or a C 1 -C 60 alkylthio group, each substituted with at least one of deuterium, —F, —Cl, —Br, —I, —SF 5 , —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 7 -C 60 alkyl aryl group, a C 7 -C 60 aryl alkyl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a C 2 -C 60 alkyl heteroaryl group, a C 2 -C 60 heteroaryl alkyl group, a C 1 -C 60 heteroaryloxy group, a C 1 -C 60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 11 )(Q 12 )(Q 13 ), —Ge(Q 11 )(Q 12 )(Q 13 ), —N(Q 14 )(Q 15 ), —B(Q 16 )(Q 17 ), —P(Q 18 )(Q 19 ), —P(═O)(Q 18 )(Q 19 ), or a combination thereof;

a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a C 1 -C 60 heteroaryloxy group, a C 1 -C 60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, or a monovalent non-aromatic condensed heteropolycyclic group;

a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a C 1 -C 60 heteroaryloxy group, a C 1 -C 60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, or a monovalent non-aromatic condensed heteropolycyclic group, each substituted with deuterium, —F, —Cl, —Br, —I, —SF 5 , —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 1 -C 60 alkylthio group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 7 -C 60 alkyl aryl group, a C 7 -C 60 aryl alkyl group, a C 6 -C 6 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a C 2 -C 60 alkyl heteroaryl group, a C 2 -C 60 heteroaryl alkyl group, a C 1 -C 60 heteroaryloxy group, a C 1 -C 60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 21 )(Q 22 )(Q 23 ), —Ge(Q 21 )(Q 22 )(Q 23 ), —N(Q 24 )(Q 25 ), —B(Q 26 )(Q 27 ), —P(Q 28 )(Q 29 ), —P(═O)(Q 28 )(Q 29 ), or a combination thereof; or

—Si(Q 31 )(Q 32 )(Q 33 ), —Ge(Q 31 )(Q 32 )(Q 33 ), —N(Q 34 )(Q 35 ), —B(Q 36 )(Q 37 ), —P(Q 38 )(Q 39 ), or —P(═O)(Q 38 )(Q 39 ),

wherein Q 1 to Q 9 , Q 11 to Q 19 , Q 21 to Q 29 , and Q 31 to Q 39 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 1 -C 60 alkylthio group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 7 -C 60 alkyl aryl group, a substituted or unsubstituted C 7 -C 60 aryl alkyl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 2 -C 60 alkyl heteroaryl group, a substituted or unsubstituted C 2 -C 60 heteroaryl alkyl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group,

wherein Ln 1 is represented by one of Formulae 11-2 to 11-6:

wherein, in Formulae 11-2 to 11-6,

R 21 to R 28 are as defined above,

R 11 to R 18 are each as defined in connection with R 10 above, and

* and *′ each indicate a binding site to M 1 .

2 . The organometallic compound of claim 1 , wherein M 1 is Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, Tm, or Rh.

3 . The organometallic compound of claim 1 , wherein M 1 is Ir, and the sum of n1 and n2 is 3.

4 . The organometallic compound of claim 1 , wherein n1 is 1 or 2, and n2 is 1 or 2.

5 . The organometallic compound of claim 1 , wherein R 10 , R 21 to R 28 , R 31 to R 37 , and R 41 to R 44 are each independently:

hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 1 -C 60 alkylthio group, —Si(Q 1 )(Q 2 )(Q 3 ), or —Ge(Q 1 )(Q 2 )(Q 3 ); or

a group represented by one of Formulae 9-1 to 9-43, 9-201 to 9-237, 10-1 to 10-129, or 10-201 to 10-350:

wherein, in Formulae 9-1 to 9-43, 9-201 to 9-237, 10-1 to 10-129, and 10-201 to 10-350, * indicates a binding site to a neighboring atom, Ph is a phenyl group, TMS is a trimethylsilyl group, and TMG is a trimethylgermyl group.

6 . The organometallic compound of claim 1 , wherein R 10 and R 21 to R 28 are each independently hydrogen, a C 1 -C 60 alkyl group, a C 1 -C 60 aryl group, —Si(Q 1 )(Q 2 )(Q 3 ), or —Ge(Q 1 )(Q 2 )(Q 3 ), and

wherein Q 1 to Q 3 are as defined in claim 1 .

7 . The organometallic compound of claim 1 , wherein R 31 to R 37 are each independently hydrogen, deuterium, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a 2-methylbutyl group, a sec-pentyl group, a tert-pentyl group, a neo-pentyl group, a 3-pentyl group, or a 3-methyl-2-butyl group.

8 . The organometallic compound of claim 1 , wherein R 41 to R 44 are each independently hydrogen, deuterium, a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, an n-pentyl group, an isopentyl group, a 2-methylbutyl group, a sec-pentyl group, a tert-pentyl group, a neo-pentyl group, a 3-pentyl group, a 3-methyl-2-butyl group, a phenyl group, a biphenyl group, a C 7 -C 60 aryl alkyl group, or a naphthyl group.

9 . The organometallic compound of claim 1 , wherein Ln 2 is represented by one of Formulae 21-1 to 21-4:

wherein, in Formulae 21-1 to 21-4,

R 31 to R 37 are as defined in claim 1 , and

* and *′ each indicate a binding site to M 1 .

10 . The organometallic compound of claim 1 , wherein Ln 2 is represented by one of Formulae 22-1 to 22-16:

wherein, in Formulae 22-1 to 22-16,

R 41 to R 44 are as defined in claim 1 , provided that none of R 41 to R 44 is hydrogen, and

* and *′ each indicate a binding site to M 1 .

11 . The organometallic compound of claim 1 , wherein the organometallic compound is represented by one of Formulae 31-2 to 31-6 or 31-8 to 31-12:

wherein, in Formulae 31-2 to 31-6 and 31-8 to 31-12,

M 1 , n1, n2, R 21 to R 28 , R 31 to R 37 , X 31 , X 32 , and R 41 to R 44 are as defined in claim 1 , and

R 11 to R 18 are each independently as defined in connection with R 10 in claim 1 .

12 . The organometallic compound of claim 1 , wherein the organometallic compound is electrically neutral.

13 . The organometallic compound of claim 1 , wherein the organometallic compound is one of the following Compounds:

14 . An organic light-emitting device, comprising:

a first electrode,

a second electrode, and

an organic layer located between the first electrode and the second electrode,

wherein the organic layer comprises an emission layer, and

wherein the organic layer further comprises at least one organometallic compound of claim 1 .

15 . The organic light-emitting device of claim 14 , wherein the emission layer comprises the at least one organometallic compound.

16 . The organic light-emitting device of claim 15 , wherein the emission layer further comprises a host, and

wherein an amount of the host in the emission layer is greater than an amount of the organometallic compound in the emission layer.

17 . The organic light-emitting device of claim 14 , wherein

the first electrode is an anode,

the second electrode is a cathode,

the organic layer further comprises a hole transport region located between the first electrode and the emission layer, and an electron transport region located between the emission layer and the second electrode,

the hole transport region comprises a hole injection layer, a hole transport layer, an electron-blocking layer, a buffer layer, or a combination thereof, and

the electron transport region comprises a hole-blocking layer, an electron transport layer, an electron injection layer, or a combination thereof.

18 . An electronic apparatus, comprising the organic light-emitting device of claim 14 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2025
From: SAMSUNG ELECTRONICS CO., LTD.
To: SAMSUNG DISPLAY CO., LTD.
Reel/Frame 072945/0453 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2022
From: PARK, BUMWOO; KWON, OHYUN; KIM, SOYEON; RAI, VIRENDRA KUMAR; MOON, JUHEE; CHO, YONGSUK; CHOI, BYOUNGKI; CHOI, JONGWON; KRAVCHUK, DMITRY
To: SAMSUNG ELECTRONICS CO., LTD.
Reel/Frame 059348/0397 →
Priority Claims (1)
KR 10-2021-0059513 · May 7, 2021 · national
Continuity (1)
Related Publication 20220380396A1 · Dec 1, 2022
References Cited (76)
US 6465115B2 · Shi et al. · 2002 [cited by applicant]
US 6596415B2 · Shi et al. · 2003 [cited by applicant]
US 9554442B2 · Kamatani et al. · 2017 [cited by applicant]
US 12152042B2 · Choi · 2024 [cited by examiner]
US 20010019782A1 · Igarashi et al. · 2001 [cited by applicant]
US 20060263630A1 · Ho · 2006 [cited by examiner]
US 20090236974A1 · Tamaru et al. · 2009 [cited by applicant]
US 20090295281A1 · Shin · 2009 [cited by examiner]
US 20100219407A1 · Kamatani · 2010 [cited by examiner]
US 20100289406A1 · Ma et al. · 2010 [cited by applicant]
US 20120068165A1 · Hayashi · 2012 [cited by applicant]
US 20150295188A1 · Kosuge · 2015 [cited by examiner]
US 20150333279A1 · Kamatani et al. · 2015 [cited by applicant]
US 20180097179A1 · Boudreault et al. · 2018 [cited by applicant]
US 20180097187A1 · Boudreault et al. · 2018 [cited by applicant]
US 20180130956A1 · Boudreault et al. · 2018 [cited by applicant]
US 20180240988A1 · Boudreault et al. · 2018 [cited by applicant]
US 20180323382A1 · Boudreault et al. · 2018 [cited by applicant]
US 20190062357A1 · Yoo et al. · 2019 [cited by applicant]
US 20190237683A1 · Boudreault et al. · 2019 [cited by applicant]
US 20190248818A1 · Boudreault · 2019 [cited by applicant]
US 20190280213A1 · Adamovich · 2019 [cited by applicant]
US 20190326527A1 · Choi et al. · 2019 [cited by applicant]
US 20190348618A1 · Kamatani et al. · 2019 [cited by applicant]
US 20200099000A1 · Zhang et al. · 2020 [cited by applicant]
US 20200127212A1 · Adamovich et al. · 2020 [cited by applicant]
US 20200259106A1 · Kamatani et al. · 2020 [cited by applicant]
US 20200308203A1 · Kim · 2020 [cited by examiner]
US 20200308205A1 · Lee et al. · 2020 [cited by applicant]
US 20210047354A1 · Shih et al. · 2021 [cited by applicant]
US 20230320210A1 · Adamovich et al. · 2023 [cited by applicant]
CN 104193783B · 2017 [cited by applicant]
CN 107892702A · 2018 [cited by applicant]
CN 108610382A · 2018 [cited by applicant]
CN 110128480A · 2019 [cited by applicant]
CN 110386951A · 2019 [cited by applicant]
CN 111253442A · 2020 [cited by applicant]
EP 3301088A1 · 2018 [cited by applicant]
EP 3398953A1 · 2018 [cited by applicant]
EP 3644384A1 · 2020 [cited by applicant]
EP 3778614A1 · 2021 [cited by applicant]
EP 3842444A1 · 2021 [cited by applicant]
JP 2000003782A · 2000 [cited by applicant]
JP 2018065786A · 2018 [cited by applicant]
JP 2018188422A · 2018 [cited by applicant]
JP 2020045340A · 2020 [cited by applicant]
JP 2020068380A · 2020 [cited by applicant]
KR 1020110111968A · 2011 [cited by applicant]
KR 20180122946A · 2018 [cited by applicant]
KR 20190107602A · 2019 [cited by applicant]
KR 1020190123228A · 2019 [cited by applicant]
KR 20200034636A · 2020 [cited by applicant]
KR 1020200115240A · 2020 [cited by applicant]
KR 1020200115268A · 2020 [cited by applicant]
WO 2012122605A1 · 2012 [cited by applicant]
WO 2019109886A1 · 2019 [cited by applicant]
WO 2019221445A1 · 2019 [cited by applicant]
WO 2019221446A1 · 2019 [cited by applicant]
Office Action issued Jan. 10, 2025 of KR Patent Application No. 10-2021-0059513. [cited by applicant]
Sungwon Yoon et al., “Red to near-infrared phosphorescent Ir(III) complexes with electron-rich chelating ligands”, Chemical Communications, 57(16), 1975-1988. (2021). [cited by applicant]
K. R. Justin Thomas et al., “Efficient Red-Emitting Cyclometalated Iridium(III) Complexes Containing Lepidine-Based Ligands,” Inorganic Chemistry, 2005, pp. 5677-5685, vol. 44, No. 16. [cited by applicant]
M. A. Baldo et al., “Highly efficient phosphorescent emission fromorganic electroluminescent devices,” Nature, Sep. 10, 1998, pp. 151-154, vol. 395. [cited by applicant]
M. A. Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., Jun. 29, 1999, pp. 4-6, vol. 75, No. 1. [cited by applicant]
Qin Wang et al., “Effects of charged self-assembled quantum dots on two-dimensional quantum transport,” Applied Physics Letters, Feb. 1, 2000, pp. 1704-1706, vol. 76, No. 13. [cited by applicant]
Raymond C. Kwong et al., “High operational stability of electrophosphorescent devices,” Applied Physics Letters, Apr. 30, 2002, pp. 162-164, vol. 81, No. 1. [cited by applicant]
Sergey Lamansky et al., “Highly Phosphorescent Bis-Cyclometalated Iridium Complexes: Synthesis, Photophysical Characterization, and Use in Organic Light Emitting Diodes,” J. Am. Chem. Soc., 2001, pp. 4304-4312, vol. 123. [cited by applicant]
Sergey Lamansky et al., “Synthesis and Characterization of Phosphorescent Cyclometalated Iridium Complexes,” Inorg. Chem., Mar. 1, 2001, pp. 1704-1711, vol. 40. [cited by applicant]
Extended European Search Report issued Sep. 9, 2022 of EP Patent Application No. 22159961.6. [cited by applicant]
Office Action issued Dec. 8, 2023 of CN Patent Application No. 202210222714.1. [cited by applicant]
Office Action issued dated Jun. 20, 2024 of CN Patent Application No. 202210222714.1. [cited by applicant]
Extended European Search Report dated Jan. 14, 2022 of EP Patent Application No. 21173643.4. [cited by applicant]
Office Action issued Apr. 1, 2025 of JP Patent Application No. 2021-082568. [cited by applicant]
Office Action issued dated Aug. 3, 2023 of KR Patent Application No. 10-2021-0061455. [cited by applicant]
Office Action issued Jun. 6, 2025 of CN Patent Application No. 202110525134.5. [cited by applicant]
Office Action mailed Feb. 27, 2024 of KR Patent Application No. 10-2021-0061455. [cited by applicant]
The partial EP Search Report dated Sep. 7, 2021 of EP App. No. 201173643.4. [cited by applicant]